Determination of acid dissociation constants of warfarin and hydroxywarfarins by capillary electrophoresis. 2015

Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
Jagiellonian University in Kraków, Faculty of Chemistry, Department of Analytical Chemistry, Ingardena St. 3, Kraków 30-060, Poland.

In this work the acid dissociation constants--pKa of warfarin and its all important oxidative metabolites have been determined by capillary electrophoresis-based methods. It has resulted in a complete description of two acid-base dissociation equilibria, yet not investigated experimentally for phase I metabolites of warfarin. The capillary electrophoresis (CE) method based on the relation between effective electrophoretic mobilities and pH has proven to be a suitable tool for pKa determination, while the spectrophotometric (CE-DAD) and the internal standard methods (IS-CE), have appeared to be promising alternative approaches. The CE-DAD approach based on the change in absorbance spectra between the acidic and basic forms is a combination between capillary electrophoresis and spectrophotometric titration, and yields very consistent values of pKa1 with CE. The IS-CE, in turn, enables an estimation of pKa1 and pKa2 from only two analytical runs, however, less accurate than CE and CE-DAD. The Debye-Hückel model has been confirmed experimentally as a good predictor of pKa values at various ionic strengths. Therefore, it has been used in determination of thermodynamic pKa1 and pKa2, referring to the zero ionic strength. The results are important from the analytical, pharmacological, and theoretical points of view.

UI MeSH Term Description Entries
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000143 Acids Chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization). An extension of the term includes substances dissolved in media other than water. (Grant & Hackh's Chemical Dictionary, 5th ed) Acid
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin
D050216 Metabolic Detoxication, Phase I Functionalization of exogenous substances to prepare them for conjugation in PHASE II DETOXIFICATION. Phase I enzymes include CYTOCHROME P450 enzymes and some OXIDOREDUCTASES. Excess induction of phase I over phase II detoxification leads to higher levels of FREE RADICALS that can induce CANCER and other cell damage. Induction or antagonism of phase I detoxication is the basis of a number of DRUG INTERACTIONS. Metabolic Detoxication, Oxidative,Metabolic Detoxification, Phase I,Phase I Detoxification,Detoxication, Oxidative Metabolic,Detoxications, Oxidative Metabolic,Detoxification, Phase I,Detoxifications, Phase I,Metabolic Detoxications, Oxidative,Oxidative Metabolic Detoxication,Oxidative Metabolic Detoxications
D019075 Electrophoresis, Capillary A highly-sensitive (in the picomolar range, which is 10,000-fold more sensitive than conventional electrophoresis) and efficient technique that allows separation of PROTEINS; NUCLEIC ACIDS; and CARBOHYDRATES. (Segen, Dictionary of Modern Medicine, 1992) Capillary Zone Electrophoresis,Capillary Electrophoreses,Capillary Electrophoresis,Capillary Zone Electrophoreses,Electrophoreses, Capillary,Electrophoreses, Capillary Zone,Electrophoresis, Capillary Zone,Zone Electrophoreses, Capillary,Zone Electrophoresis, Capillary

Related Publications

Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
May 2004, Journal of chromatography. A,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
August 2020, Electrophoresis,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
August 2008, Journal of separation science,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
May 2005, Electrophoresis,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
August 2015, Journal of chromatography. A,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
May 2000, Journal of chromatography. A,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
February 1999, Journal of chromatography. A,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
October 1994, Journal of pharmaceutical sciences,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
October 2003, Journal of pharmaceutical and biomedical analysis,
Paweł Nowak, and Paulina Olechowska, and Mariusz Mitoraj, and Michał Woźniakiewicz, and Paweł Kościelniak
October 1999, Electrophoresis,
Copied contents to your clipboard!